ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 147 filers reported holding ANI PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 10.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,301,000 | -22.1% | 23,006 | -8.0% | 0.35% | -25.2% |
Q2 2018 | $1,670,000 | +14.7% | 25,007 | 0.0% | 0.46% | +12.6% |
Q1 2018 | $1,456,000 | -22.1% | 25,007 | -13.8% | 0.41% | -17.1% |
Q4 2017 | $1,870,000 | +22.8% | 29,009 | +0.0% | 0.50% | +21.8% |
Q3 2017 | $1,523,000 | +25.1% | 29,007 | +11.5% | 0.41% | +23.2% |
Q2 2017 | $1,217,000 | +55.4% | 26,005 | +64.5% | 0.33% | +71.1% |
Q1 2017 | $783,000 | -18.3% | 15,805 | 0.0% | 0.19% | -14.2% |
Q4 2016 | $958,000 | -8.7% | 15,805 | 0.0% | 0.23% | -6.6% |
Q3 2016 | $1,049,000 | +13.2% | 15,805 | -4.8% | 0.24% | +7.1% |
Q2 2016 | $927,000 | +111.6% | 16,605 | +27.7% | 0.23% | +89.9% |
Q1 2016 | $438,000 | -15.6% | 13,005 | +13.0% | 0.12% | -8.5% |
Q4 2015 | $519,000 | +19.0% | 11,505 | +12.7% | 0.13% | +12.1% |
Q3 2015 | $436,000 | -15.0% | 10,205 | +10.9% | 0.12% | -35.9% |
Q2 2015 | $513,000 | +7.8% | 9,204 | +20.9% | 0.18% | -2.7% |
Q1 2015 | $476,000 | – | 7,615 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |